Table 1 summarizes the age at diagnosis, tumor diameter, lymph node status, pathological stage, histological features, presence of TILs and CD8-positive T cells, and PD-L1 expression for the 230 TNBC patients (Table S1 summarizes patient characteristics by GZMB cut off value (1% or 5%)). The gene discussed is CD8A; the disease is neoplasm.